Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Douglas Carr currently holds 505,094 shares of Century Therapeutics, Inc. (IPSC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas Carr has been a net seller of IPSC stock. They have purchased $0 and sold $11.8K worth of shares.
Douglas Carr's most recent insider trade was on Jun 12, 2026, when they sold 1,654 shares at $2.23 per share.
Douglas Carr serves as Executive at Century Therapeutics, Inc. (IPSC). They have executed 18 insider transactions totaling $11.8K over their tenure at the company.
Douglas Carr holds the position of Executive at Century Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Douglas Carr has shown a selling trading pattern, with $0 in total purchases and $11.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Douglas Carr was on Nov 1, 2023, when they sold $24.8K worth of IPSC shares. This transaction involved 16,611 shares at $1.49 per share.
Douglas Carr currently owns 505,094 shares of Century Therapeutics, Inc. (IPSC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Douglas Carr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Douglas Carr has 18 Form 4 filings on record as an insider at Century Therapeutics, Inc..
Set alerts for Douglas Carr and 40,000+ other insiders.